Grand House Mulia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Grand House Mulia Tbk. trades at Rp206 (market cap 311.85B, 4.24M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.1× Grand House Mulia Tbk.'s market cap, and Grand House Mulia Tbk. is more actively traded (4.24M versus 848.2K). Which is the better fit depends on your goals.
| HOMI | LABS | |
|---|---|---|
Market Cap | 311.85B | 651.75B |
Volume | 4.24M | 848.2K |
Lot | 42.43K | 8.48K |
Turnover | 843.27M | 140.51M |
Average Price | 198.77 | 165.66 |
Value | 843.27M | 140.51M |
Indicative Equilibrium Price | 198 | 168 |
Indicative Equilibrium Volume | 39.3K | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.
Read more on HOMI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →